FREE Webinar - Advances in High Throughput Formulation Screening - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Untitled Document

FREE Webinar - Advances in High Throughput Formulation Screening

Wednesday 20th November 2013 at 3 pm GMT, 4 pm CET, 10 am EST

In response to the challenges of new product formats and increased regulatory scrutiny, the early developability of biotherapeutic candidates based on stability and formulation characteristics is becoming ever more important. This interactive webinar, brought to you by Avacta Analytical and Synthon Biopharmaceuticals, will address the themes and challenges in this area.

The webinar will demonstrate how high throughput protein thermal stability analysis is widely used as a predictive tool to accelerate formulation development and candidate selection, or to optimise processing conditions downstream. It will focus on the formulation of a monoclonal antibody and the capabilities of high throughput screening to predict degradation, characterise stability and enhance workflows, as well as offering a case study in an industrial setting.

Click here to learn more and to register.

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
Which of the following business challenge poses the greatest threat to your company?
Building a sustainable pipeline of products
Attracting a skilled workforce
Obtaining/maintaining adequate financing
Regulatory compliance
Building a sustainable pipeline of products
25%
Attracting a skilled workforce
29%
Obtaining/maintaining adequate financing
11%
Regulatory compliance
36%
View Results
Eric Langer Outsourcing Outlook Eric LangerBiopharma Outsourcing Activities Update
Cynthia Challener, PhD Ingredients Insider Cynthia Challener, PhDAppropriate Process Design Critical for Commercial Manufacture of Highly Potent APIs
Jill Wechsler Regulatory Watch Jill Wechsler FDA and Manufacturers Seek a More Secure Drug Supply Chain
Sean Milmo European Regulatory WatcchSean MilmoQuality by Design?Bridging the Gap between Concept and Implementation
Medicare Payment Data Raises Questions About Drug Costs
FDA Wants You!
A New Strategy to Tackle Antibiotic Resistance
Drug-Diagnostic Development Stymied by Payer Concerns
Obama Administration Halts Attack on Medicare Drug Plans
FindPharma Custom Search

Click here